Blotter

In State of the Union, Trump misrepresents administration’s
support for medical research

Benjamin Corb
Feb. 5, 2020

President Donald Trump used a portion of last night’s State of the Union address to whitewash his administration’s attempts to undermine and defund science. Roughly three-quarters of the way through the speech, he said:

Read the ASBMB's response

“President Donald Trump took a revisionist look back at his administration’s support for biomedical research that leads to life-saving breakthroughs." Read more.

“We have launched ambitious new initiatives to substantially improve care for Americans with kidney disease, Alzheimer's, and those struggling with mental health challenges.  And because the Congress funded my request, we are pursuing new cures for childhood cancer, and we will eradicate the AIDS epidemic in America by the end of the decade.”

Specifically attention-grabbing to me was “And because Congress funded my request.”

Let’s be very clear about the president, his record on funding biomedical research, and what the status of funding is. 

Today, the National Institutes of Health operates at an annual budget of $40.2 billion.  That is the fiscal year 2020 enacted level, approved by Congress and signed into law by Trump in late 2019.  The $40.2 billion marked a $2.6 billion (6.6%) increase over the fiscal 2019 enacted spending level.  

Trump’s budget request for fiscal year 2020 for the NIH was $34.4 billion.  This number represented a $4.9 billion (12.6%) cut from fiscal 2019 enacted levels.  With the lone exception of buildings and facilities, under Trump’s fiscal 2020 budget request, all institutes, centers and budget activity would have been cut.

It was Congress, with strong bipartisan support, that rejected Trump’s budget request and funded the NIH at a level 22% above the administration’s budget request for fiscal 2020. 

This is the story and the legacy of the Trump administration as it relates to funding for medical research that leads to cures and breakthroughs.

For fiscal 2019, Trump’s initial budget request called for a 27% cut to NIH funding — and it was followed by a supplement that reversed the cuts and requested level funding.

Trump’s first budget request in 2017 called for a 22% cut to the NIH, which would have brought NIH funding to its lowest level since 2002.  Once again, these cuts were rejected by a Congress supportive of investments in medical research.

Before last night’s State of the Union, I wrote about how Trump has largely left science out of his previous addresses to Congress.  In his previous speeches, while he had spoken more than 16,000 words, he mentioned science, research and cures only six times. I argued that the lack of rhetoric from the president supporting science in his speeches matched the lack of support science has seen from this administration.

One section of one speech does not make the president a champion of biomedical research or innovation.  Unless and until we see demonstrated changes in the administration’s attitude toward investing in life-saving research, we are left with few options other than seeing the president’s comments as opportunistic and an attempt to gloss over just how uninterested he is in supporting American innovation and the NIH.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Benjamin Corb

Benjamin Corb is the former director of public affairs at ASBMB.

Related articles

Immune cells can adapt to invading pathogens
Kathleen Abadie, Elisa Clark & Hao Yuan Kueh
From the journals: JLR
Joseph Heath
2024 voter guide
ASBMB Today Staff

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Opinions

Opinions highlights or most popular articles

A paleolithic peer review
Essay

A paleolithic peer review

April 18, 2024

You might think review panels have only been around for the last century or so. You would be mistaken.

Early COVID-19 research is riddled with poor methods and low-quality results
News

Early COVID-19 research is riddled with poor methods and low-quality results

April 13, 2024

The pandemic worsened, but didn’t create, this problem for science.

So, you went to a conference. Now what?
Professional Development

So, you went to a conference. Now what?

April 12, 2024

Once you return to normal lab life, how can you make use of everything you learned?

My guitar companion
Essay

My guitar companion

April 11, 2024

A scientist takes a musical journey through time and around the world.

Catalyzing change and redefining purpose
Essay

Catalyzing change and redefining purpose

March 28, 2024

To mark Women’s History Month, Sudha Sharma writes about her journey from focusing on her own research program to being part of a collaborative COVID-19 project.

The power of sabbaticals
Essay

The power of sabbaticals

March 28, 2024

To mark Women’s History Month, Nicholas Rhind writes about learning techniques in other researchers’ labs that empower the work in his own.